Clinical Trial Update: Optimization of Golimumab Treatment in Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on optimizing golimumab treatment for ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Hospital de Manises | Conditions: Colitis, Ulcerative | Phase 4 | Status: UNKNOWN